Safety concerns for the use of calcium channel blockers in pregnancy for the treatment of spontaneous preterm labour and hypertension: A systematic review and meta-regression analysis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 9, 2010, Pages 1030-1038

  Khan, Khalid ^a   Zamora, Javier ^b   Lamont, Ronald F ^c   Van Geijn Hp, Herman ^d   Svare, Jens ^e   Santos Jorge, Carlos ^f   Jacquemyn, Yves ^g   Husslein, Peter ^h   Helmer H, Hanns ^h   Dudenhausen, Joachim ⁱ   Di Renzo, Gian Carlo ^j   Roura, Luis Cabero ^k   Beattie, Bryan ^l  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF PORTO   (Portugal)

^g ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^h UNIVERSITY OF VIENNA   (Austria)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j UNIVERSITY OF PERUGIA   (Italy)

^k HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

^l UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

more..

Author keywords

calcium channel blockers; hypertension; Nifedipine; pre eclampsia; pregnancy; preterm birth; preterm labour; safety; systematic review; tocolytic

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FELODIPINE; ISRADIPINE; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NISOLDIPINE; NITRENDIPINE; VERAPAMIL;

ACIDOSIS; AREFLEXIA; ASCITES; ASPHYXIA; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CYANOSIS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG USE; DYSPNEA; FETUS DISTRESS; FETUS MORTALITY; FLUSHING; HEART INFARCTION; HEART PALPITATION; HUMAN; HYPERBILIRUBINEMIA; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; HYPOXIA; ILEUS; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LUNG EDEMA; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MORBIDITY; NAUSEA; NECROTIZING ENTEROCOLITIS; OGILVIE SYNDROME; OLIGURIA; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERAL PSYCHOSIS; REGRESSION ANALYSIS; RESPIRATORY DISTRESS; REVIEW; SEPTICEMIA; SIDE EFFECT; SOLUTIO PLACENTAE; SYSTEMATIC REVIEW; TACHYCARDIA; TACHYPNEA; THORAX PAIN; THROMBOCYTE COUNT; VOMITING;

CALCIUM CHANNEL BLOCKERS; DRUG TOXICITY; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REGRESSION ANALYSIS; UNITED STATES;

EID: 77955875046     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767050903572182     Document Type: Review

References (73)

1. Magowan BA, Bain M, Juszczak E, Mcinneny K. Neonatal mortality amongst Scottish preterm singleton births (1985- 1994). Br J Obstet Gynaecol 1998;105:1005-1010.
2. Wood NS, Marlow N, Costeloe K, Wilkinson AR. Neurologic and developmental disability after extremely preterm birth. N Engl J Med 2000;343:378-384.
3. Villar J, Escurra EJ. Pre-term delivery syndrome: the unmet need. New perspectives for the effective treatment of pre-term labour - an international consensus. Res Clin Forums 1994; 16:169-238
4. Besinger R, Iannucci T. Tocolytic therapy. In: Elder MG, Lamont RF, Romero R, editors. Preterm labor. New York: Churchill Livingstone; 1997. pp 243-297
5. Anon. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. The Canadian Preterm Labor Investigators Group. N Engl J Med 1992;327:308-312
6. Leveno KJ, Cunningham FG. Beta-adrenergic agonists for preterm labor. N Engl J Med 1992;327:349-351
7. Lamont RF. The pathophysiology of pulmonary oedema with the use of beta-agonists. Br J Obstet Gynaecol 2000;107:439-444.
8. Grimes DA, Nanda K. Magnesium sulphate tocolysis: time to quit. Obstet Gynecol 2006;108:986-989.
9. Royal College of Obstetricians and Gynaecologists. Tocolytic drugs for the women in preterm labour. Clinical Guideline No. 1(B), October 2002.
10. European Atosiban Study Group. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. Acta Obstet Gynecol Scand 2001;80:413-422.
11. French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001;98:177-185.
12. Moutquin JM, Sherman D, Cohen H, Mohide PT, Hochner- Celnikier D, Fejgin M, Liston RM, Dansereau J, Mazor M, Shalev E, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 2000;182:1191-1199.
13. Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. BJOG 2001;108:133-142.
14. Lamont RF, Khan KS, Beattie B, Cabero Roura L, Di Renzo GC, Dudenhausen JW, Helmer H, Svare J, van Geijn HP; Steering Group of the International Preterm Labour Council. The quality of nifedipine studies used to assess tocolytic efficacy: a systematic review. J Perinat Med 2005;33:287-295.
15. Oei SG, Oei SK, Brolmann HA. Myocardial infarction during nifedipine therapy for preterm labour. N Engl J Med 1999; 340:154.
16. Bal L, Thierry S, Brocas E, Adam M, Van de Louw A, Tenaillon A. Pulmonary edema induced by calcium-channel blockade for tocolysis. Anesth Analg 2004;99:910-911.
17. Vaast P, Dubreucq-Fossaert S, Houfflin-Debarge V, Provost- Helou N, Ducloy-Bouthors AS, Puech F, Subtil D. Acute pulmonary oedema during nicardipine therapy for preterm labour, report of 5 cases. Eur J Obstet Gynaecol 2004;113:98-99.
18. Hodges R, Barkehall-Thomas A, Tippett C. Maternal hypoxia associated with nifedipine for threatened preterm labour. Br J Obstet Gynaecol 2004;111:380-381.
19. Verhaert D, Van Acker R. Acute myocardial infarction during pregnancy. Acta Cardiol 2004;59:331-339.
20. van Veen AJ, Pelinck MJ, Pampus MG, Erwich JJ. Severe hypotension and fetal death due to tocolysis with nifedipine. Br J Obstet Gynaecol 2005;112:509-510.
21. van Geijn HP, Lenglet JE, Bolte AC. Nifedipine trials: effectiveness and safety aspects. Br J Obstet Gynaecol 2005; 112:79-83.
22. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066-1074.
23. Lamont RF. International Preterm Labor Council 2003. Evidence based labor ward guidelines for the diagnosis and treatment of spontaneous preterm labour. J Obstet Gynaecol 2003;23:469-478.
24. Lamont RF, Dunlop PDM, Crowley P, Levene MI, Elder MG. Comparative mortality and morbidity of infants transferred in utero or postnatally. J Perinat Med 1983;11:200-203.
25. Crowley P. Prophylactic steroids for preterm birth. Cochrane Database Syst Rev 2001;CD000065.
26. Cuervo GL, Clarke M. Balancing benefits and harm in health care. BMJ 2003;327:65-66.
27. Ernst E, Pittler MH. Assessment of therapeutic safety in systematic reviews: literature review. BMJ 2001;323:546.
28. Ioannidis JPA, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001;285:437-443.
29. Loke YK, Derry S. Reporting of adverse drug reactions in randomised controlled trials - a systematic survey. BMC Clin Pharmacol 2001;1:3.
30. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2006;19;3:CD001449.
31. King JF, Flenady V, Papatsonis D, Dekker G, Carbonne B. Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipine. Aust N Z J Obstet Gynaecol 2003;43:192-198.
32. Coomarasamy A, Knox EM, Gee H, Song F, Khan KS. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials. BJOG 2003;110:1045-1049.
33. Lamont RF. A quality assessment tool to evaluate tocolytic studies. BJOG 2006;113(Suppl 3):96-99.
34. Ross SD: Drug-related adverse events - A readers' guide to assessing literature reviews and meta-analyses. Arch Intern Med 2001;161:1041-1046.
35. Bagnall A-M, Jones L, Ginnelly L, Lewis R, Glanville J, Gilbody S, Davies L, Torgerson D, Kleijen J. A systematic review of atypical antipsychotic drugs in schizophrenia. Health Technol Assess 2003;7:1-193.
36. Khan KS, ter Riet G, Glanville J, Sowden AJ, Kleijnen J. Undertaking systematic reviews of research on effectiveness. CRD's guidance for carrying out or commissioning reviews. CRD report number 4, 2nd ed. York: NHS Centre for Reviews and Dissemination, University of York; 2001.
37. Khan KS, Kunz R, Kleijnen J, Antes G. Systematic reviews to support evidence-based medicine: how to review and apply findings of systematic reviews. London: Royal Society of Medicine; 2003.
38. Downs S, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998;52:377-384.
39. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. Ottawa Health Research InstituteWeb site. http://www.ohri.ca/ programs/ clinical-epidemiology/oxford.htm. Accessed January 21, 2010.
40. Glasziou P, Irwig L, Bain C, Colditz G. Frequency and rate. In: Systematic reviews in health care: a practical guide. Cambridge University Press 2001; pp 67-73.
41. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey SG, Altman DG, editors. Systematic reviews in health care: meta-analysis in context, 2nd ed. London: BMJ Books; 2001;285-312.
42. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066-1074.
43. Diggle P, Heagerty P, Liang K, Zeger S. Analysis of longitudinal data, 2nd ed. Oxford: Oxford University Press; 2002.
44. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
45. Song F, Eastwood AJ, Gilbody S, Duley L, Sutton AJ. Publication and related biases. Health Technol Assess 2000; 4:1-115.
46. Sterne J, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 2001;323:101-105.
47. Aya AG, Bruelle P, Lefrant JY, Saissi G, Ferrer JM, Eledjham JJ. Accidental nicardipine overdosage without serious maternal or neonatal consequence. Anaesth Intensive Care 1996; 24:99-101.
48. Blickstein I, Hagay Z, Goldchmit R, Insler V. Nifedipine may cause falsely increased spectrophotometric values of urinary vanillylmandelic acid. Clin Chem 1993;39:365-366
49. Ferguson JE II, Siukola LV, Albright GA. Use of verapamil for paroxysmal supraventricular tachycardia during epidural anesthesia for cesarean section. Am J Perinatol 1988;5:128-130.
50. Jost U, Hirschauer M, Heimbach W. Postpartum pulmonary oedema associated with preventive therapy for premature labour. Anasth Intensivther Notf Med 1982;17:225-227.
51. Impey L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynaecol 1993;100:959-961.
52. Ben-Ami M, Giladi Y, Shalev E. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol 1994;101:262-263.
53. Pecha RE, Danilewitz MD. Acute pseudo-obstruction of the colon (Ogilvie's syndrome) resulting from combination tocolytic therapy. Am J Gastroenterol 1996;91:1265-1266.
54. Beckmann M, Schmidt EH, Beller FK. Ileus after removal of a large ovarian tumor during pregnancy. Consequence of preventive tokolysis? Med Welt 1980;31:193-195.
55. Rey E, Duperron L, Gauthier R, Lemay M, Grignon A, LeLorier J. Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: a case report. Am J Obstet Gynecol 1985;153:311-312.
56. O'Donnell, Mertl SY, Kelly WN. Calcium-channel blocker withdrawal in a pregnant woman. Am J Ther 1999;6:61-66.
57. Snyder SW, Cardwell MS. Neuromuscular blockade with magnesium sulfate and nifedipine. Am J Obstet Gynecol 1989;161:35-36.
58. Rhabbour M, Lenoir S, Bouissou F, Rolland M, Fournie A. Fetal and neonatal effects of maternal treatment with angiotensin converting enzyme inhibitor. Arch Pediatr 1994;1:497-500.
59. Shen O, Entebi E, Yagel S. Congenital hypertrophic cardiomyopathy associated with in utero verapamil exposure. Prenat Diagn 1995;15:1088-1089.
60. Scott AA, Purohit DM. Neonatal renal failure: a complication of maternal antihypertensive therapy. Am J Obstet Gynecol 1989;160(5 Pt 1):1223-1224.
61. Sawaya GF, Robertson PA. Hepatotoxicity with the administration of nifedipine for treatment of preterm labor. Am J Obstet Gynecol 1992;167:512-513.
62. Rienhardt GW, Steyn PS, Odendaal HJ. Conservative management of severe chronic hypertension in pregnancy. Eur J Obstet Gynecol Reprod Biol 1994;57:215-217.
63. Arnoux P, Seyral P, Llurens M, Djiane P, Potier A, Unal D, Cano JP, Serradimigni A, Rouault F. Amiodarone and digoxin for refractory fetal tachycardia. Am J Cardiol 1987;59:166-167.
64. Sheik AU, Harper MA. Myocardial infarction during pregnancy: management and outcome of two pregnancies. Am J Obstet Gynecol 1992;167:512-513.
65. Kaul AF, Osathanondh R, Safon LE, Frigoletto FD Jr, Friedman PA. The management of preterm labor with the calcium channel-blocking agent nifedipine combined with the beta-mimetic terbutaline. Drug Intell Clin Pharm 1985; 19: 369-371.
66. Rosbotham JL, Johnson A, Haque KN, Holden CA. Painful subcutaneous fat necrosis of the newborn associated with intra-partum use of a calcium channel blocker. Clin Exp Dermatol 1998;23:19-21.
67. Tetsuo M, Ishimatsu J, Hori D, Yakushiji M, Hamada T. Evaluation of hemodynamic changes and intrauterine conversion of fetal supraventricular tachycardia. Acta Obstet Gynecol Scand 1995;74:647-649.
68. Trice L, Bennert H, Stubblefield PG. Massive vulvar edema complicating tocolysis in a patient with twins. A case report. J Reprod Med 1996;41:121-124.
69. Hata T, Manabe A, Hata K, Kitao M. Changes in blood velocities of fetal circulation in association with fetal heart rate abnormalities: effect of sublingual administration of nifedipine. Am J Perinatol 1995;12:80-81.
70. Husslein P, Cabero Roura L, Dudenhausen JW, Helmer H, Frydman R, Rizzo N, Schneider D. Atosiban versus usual care for the management of preterm labor. J Perinat Med 2007; 35:305-313.
71. Herbst A, Wide-Swensson D, Ingemarsson I. Significant delay of birth in advanced preterm labour at 23 gestational weeks with an oxytocin antagonist. Eur J Obstet Gynecol Reprod Biol 2003;108:109-110.
72. Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B. Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet Gynecol 2001;97:840-847.
73. Oei SG, Mol BW, de Kline MJK, Brolmann HA. Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis. Acta Obstet Gynecol Scand 1999;78:783-788.